CHRONIC LIVER DISEASE

This study looks at whether giving copper supplements to people with cirrhosis (scarring of the liver) who have low copper levels can improve liver function and overall health. About 30 adults with cirrhosis and low or borderline copper will take copper or a placebo for a set tim…

This study tests a medicine made from human placenta, called LAENNEC, in people with chronic liver disease. It compares giving the medicine as an IV drip versus a shot under the skin. The main goal is to see if the IV form lowers liver enzyme (ALT) levels more effectively over 6 …

This study compares two ways to screen for liver cancer in people with cirrhosis who are at high risk. About 944 participants will either get a standard ultrasound every six months or an ultrasound plus a quick MRI (Fast-MRI). The goal is to see if adding Fast-MRI finds more earl…

This study tests a non-invasive ultrasound exam (Hepatoscope) to screen for liver scarring and fat buildup in 200 adults at risk for chronic liver disease. Participants with elevated stiffness readings will be referred to a liver specialist. The goal is to see if this tool can ac…

This study is testing whether a blood test called hepatomiR can predict serious liver problems like fluid buildup, bleeding, or confusion in people with long-term liver disease. Researchers will follow 156 patients to see how well the test works. The goal is to improve future ris…

This study aims to see if a special ultrasound done through an endoscope (EUS-SWE) can accurately measure liver scarring (fibrosis) in people with fatty liver disease. About 300 adults will get the new ultrasound, a standard liver biopsy, and a FibroScan. The goal is to find out …

This study looks at the social and economic challenges faced by people with chronic liver disease, such as trouble paying for food or housing. Researchers will survey 400 patients and their doctors to find out what needs are most common and whether patients want their medical tea…